Glenn M. Marshall

Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer

Marie Wong, Chelsea Mayoh, Loretta M. S. Lau et al. · Nature Medicine · 2020 · 404 citations · Full text

Life Sciences, Genetics, Oncology +14

<i>ODC1</i> Is a Critical Determinant of <i>MYCN</i> Oncogenesis and a Therapeutic Target in Neuroblastoma

Michael D. Hogarty, Murray D. Norris, Kimberly Davis et al. · Cancer Research · 2008 · 260 citations · Full text

Medicine, Cancer Biology, Oncology +17

The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse

Richard B. Lock, Natalia Liem, Monica L. Farnsworth et al. · Blood · 2002 · 205 citations

Medicine, Immunology, Oncology +14

Association of High-Level <i>MRP1</i> Expression With Poor Clinical Outcome in a Large Prospective Study of Primary Neuroblastoma

Michelle Haber, Janice Smith, Sharon B. Bordow et al. · Journal of Clinical Oncology · 2006 · 173 citations

Medicine, Genetics, Oncology +15

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

Jo Lynne Rokita, Komal S. Rathi, Maria Cardenas et al. · Cell Reports · 2019 · 173 citations · Full text

Medicine, Oncology, Pediatrics +17